These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18467380)

  • 1. PD98059 enhances C2 myoblast differentiation through p38 MAPK activation: a novel role for PD98059.
    Al-Shanti N; Stewart CE
    J Endocrinol; 2008 Jul; 198(1):243-52. PubMed ID: 18467380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor (IGF)-binding protein-related protein-1: an autocrine/paracrine factor that inhibits skeletal myoblast differentiation but permits proliferation in response to IGF.
    Haugk KL; Wilson HM; Swisshelm K; Quinn LS
    Endocrinology; 2000 Jan; 141(1):100-10. PubMed ID: 10614628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O; Cantley LC
    Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK.
    Riuzzi F; Sorci G; Donato R
    J Cell Physiol; 2006 May; 207(2):461-70. PubMed ID: 16419039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2.
    Weyman CM; Wolfman A
    Endocrinology; 1998 Apr; 139(4):1794-800. PubMed ID: 9528964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of IGF-1 on proliferation and differentiation of primary human embryonic myoblasts].
    Cen S; Zhang J; Huang F; Yang Z; Xie H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jan; 22(1):84-7. PubMed ID: 18361246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
    Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
    J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: relevance to disease and ageing?
    Sharples AP; Al-Shanti N; Stewart CE
    J Cell Physiol; 2010 Oct; 225(1):240-50. PubMed ID: 20506232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential roles of MAPK-Erk1/2 and MAPK-p38 in insulin or insulin-like growth factor-I (IGF-I) signaling pathways for progesterone production in human ovarian cells.
    Seto-Young D; Avtanski D; Varadinova M; Park A; Suwandhi P; Leiser A; Parikh G; Poretsky L
    Horm Metab Res; 2011 Jun; 43(6):386-90. PubMed ID: 21448845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation.
    Adi S; Bin-Abbas B; Wu NY; Rosenthal SM
    Endocrinology; 2002 Feb; 143(2):511-6. PubMed ID: 11796505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of C2C12 myoblasts expressing lamin A mutated at a site responsible for Emery-Dreifuss muscular dystrophy is improved by inhibition of the MEK-ERK pathway and stimulation of the PI3-kinase pathway.
    Favreau C; Delbarre E; Courvalin JC; Buendia B
    Exp Cell Res; 2008 Apr; 314(6):1392-405. PubMed ID: 18294630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial synergistic interactions of TNF-alpha and IL-6 in C2 skeletal myoblasts--potential cross-talk with IGF system.
    Al-Shanti N; Saini A; Faulkner SH; Stewart CE
    Growth Factors; 2008 Apr; 26(2):61-73. PubMed ID: 18428025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts.
    Samuel DS; Ewton DZ; Coolican SA; Petley TD; McWade FJ; Florini JR
    Horm Metab Res; 1999; 31(2-3):55-64. PubMed ID: 10226782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and Akt/PKB pathways.
    Deldicque L; Theisen D; Bertrand L; Hespel P; Hue L; Francaux M
    Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1263-71. PubMed ID: 17652429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells.
    Lin CW; Yang LY; Shen SC; Chen YC
    J Cell Physiol; 2007 Sep; 212(3):666-74. PubMed ID: 17458902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60.
    Kikuchi H; Yuan B; Yuhara E; Takagi N; Toyoda H
    Int J Oncol; 2013 Dec; 43(6):2046-56. PubMed ID: 24064676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol.
    Saini A; Al-Shanti N; Sharples AP; Stewart CE
    Exp Physiol; 2012 Mar; 97(3):400-18. PubMed ID: 22125309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of mitogen-activated protein kinase in insulin and insulin-like growth factor I (IGF-I) signaling cascades for progesterone and IGF-binding protein-1 production in human granulosa cells.
    Seto-Young D; Zajac J; Liu HC; Rosenwaks Z; Poretsky L
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3385-91. PubMed ID: 12843192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells.
    Zhang W; Lee JC; Kumar S; Gowen M
    J Bone Miner Res; 1999 Apr; 14(4):528-35. PubMed ID: 10234573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.